CABO-CHANCE study: A real-life world study of cabotegravir plus rilpivirine long-acting intramuscular in ART-experienced people with HIV.
- DOI
- 10.1016/j.ijantimicag.2026.107909
- Published
- 2026-07-06
- Container
- Int J Antimicrob Agents
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ijantimicag.2026.107909,
title = {CABO-CHANCE study: A real-life world study of cabotegravir plus rilpivirine long-acting intramuscular in ART-experienced people with HIV.},
author = {Hidalgo-Tenorio C and García-Aguilera M and Santos IL and Ruiz-Sancho A and Rivero A and López-Lirola A and Omar M and Romero A and Bernal E and Martinez O and López T and Sorni P and García-Ocaña P and Moreno S and Sanjoaquín I and Blanco JR and Garcia C.},
year = {2026},
journal = {Int J Antimicrob Agents},
doi = {10.1016/j.ijantimicag.2026.107909},
url = {https://doi.org/10.1016/j.ijantimicag.2026.107909}
}RIS
TY - JOUR TI - CABO-CHANCE study: A real-life world study of cabotegravir plus rilpivirine long-acting intramuscular in ART-experienced people with HIV. AU - Hidalgo-Tenorio C AU - García-Aguilera M AU - Santos IL AU - Ruiz-Sancho A AU - Rivero A AU - López-Lirola A AU - Omar M AU - Romero A AU - Bernal E AU - Martinez O AU - López T AU - Sorni P AU - García-Ocaña P AU - Moreno S AU - Sanjoaquín I AU - Blanco JR AU - Garcia C. PY - 2026 JO - Int J Antimicrob Agents DO - 10.1016/j.ijantimicag.2026.107909 UR - https://doi.org/10.1016/j.ijantimicag.2026.107909 ER -
APA
C, H., M, G., IL, S., A, R., A, R., A, L., M, O., A, R., E, B., O, M., T, L., P, S., P, G., S, M., I, S., JR, B., & C., G. (2026). CABO-CHANCE study: A real-life world study of cabotegravir plus rilpivirine long-acting intramuscular in ART-experienced people with HIV.. Int J Antimicrob Agents. https://doi.org/10.1016/j.ijantimicag.2026.107909
Source records
- europe-pmc · retrieved 2026-09-26T19:19:23.665Z